Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Rhabdoid Tumor

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Rhabdoid Tumor

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 6 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      8 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00003469 · Registry condition search · Scope: narrower

      Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

      2 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00945009 · Source cited / selected · Scope: narrower

      Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

      5 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT02162732 · Registry condition search · Scope: narrower

      Molecular-Guided Therapy for Childhood Cancer

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT02601950 · Source cited / selected · Scope: narrower

      A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

      6 outcome links · 8 safety-group records · 0 quality-of-life measures

      →

      NCT03043391 · Registry condition search · Scope: narrower

      Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03213665 · Source cited / selected · Scope: narrower

      Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03213678 · Registry condition search · Scope: narrower

      Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATC

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT04537715 · Registry condition search · Scope: narrower

      Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-rhabdoid-tumor
        binding id
        ncit-C3808
        source collection
        ncit-concept
        source key
        C3808
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice